CLINICAL_TRIALS trial_result · 2023-01-26

Clinical Trial Update: A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia [Phase 2]

Phase 2 trial evaluating CSF-1 for presbyopia has completed; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Orasis Pharmaceuticals Ltd. | Conditions: Presbyopia | Phase 2 | Status: COMPLETED | Results posted: 2023-01-26